Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Disappointing Tests Results for Pompe Disease Drug
On Friday, shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) reached at $12.57 price level during last trade its distance from 20 days simple moving average was -37.73%, and its distance from …
Read More